Patients Rising Now signed onto a letter to the Federal Trade Commission (FTC) regarding Pharmacy Benefit Managers (PBMs) with 105 other associations. This was a letter we signed onto in addition to the comments we submitted on behalf of our own organization. The PBM issue is so critical to patient access to care that we wanted to take any opportunity we could to support the call for reform!
Categories
- Access
- Actions
- California
- Comment Letters
- Copay Accumulators
- Copay Assistance
- COVID-19
- Drug Costs
- FDA
- Featured
- Featured Action
- Federal Issues
- Health Insurance
- Health Policy
- ICER
- Illinois
- Issues
- Letters Submitted
- Letters Supported
- Massachusetts
- Medicaid
- Medicare
- Medicare Part D
- News
- Op-Ed
- Out of Pocket Costs
- Pharmacy Benefit Managers
- Podcast
- Prescription Drugs
- Press Releases
- Public Statement
- QALY
- State Issues
- Statements
- Step Therapy
- Surprise Billing
- Terry's Hot Take
- Uncategorized
- Value Based Insurance Design
- Value Frameworks
- Virtual Advocacy Chat
Tags
21st Century Cures Act
340B
Access to Care
Advocacy
Alzheimer's
Biden Administration
biosimilars
Cancer
cms
Copay Accumulators
copay assistance
COVID-19 Vaccine
drug costs
Drug Manufacturing
Drug Pricing
drug rebate
fail first
FDA
H.R.3
Healthcare Inequities
Health Insurance
hospital bills
HR 3708
hsa
ICER
Insurance design
Joe Biden
Lupus
medicare Part B
medicare part D
Nonmedical Switching
open enrollment
Out of Pocket Costs
PBM
PBMs
pharmacy benefit managers
Price Transparency
Prior Authorization
QALY
Rare Disease
Right to Repair
Step Therapy
Telehealth
transparency
Value Framework
Recent Posts
- Hospitals Fail CMS Price Transparency Mandates, Face Hefty Fines
- Terry’s Hot Take – July 2022
- How Chronic Illness Impacts Families: Season 3 | Episode 25
- Guide for Commenting on ICER’s Draft Evidence Report on Treatments for Amyotrophic Lateral Sclerosis (ALS)
- Patients on Capitol Hill: Season 3 | Episode 24